CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Nigeria

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Nigeria


  • Products Id :- GDHC0029CHR
  • |
  • Pages: 85
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Nigeria

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Nigeria". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Nigeria. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Nigeria. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape in Nigeria, and includes-

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical market (GlaxoSmithKline, Pfizer, May & Baker, Novartis and Fidson) and profile and SWOT analyses of the major player in the medical device market (Roche Diagnostics)

- Porter's five forces analysis for pharmaceutical and medical devices market of Nigeria

- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the Nigerian healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to-

- Develop business strategies by understanding the trends shaping and driving the Nigerian healthcare market

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

- Identify, understand, and capitalize on the opportunities and challenges in the Nigerian healthcare market.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary

Overview of Pharmaceutical Market

Overview of Medical Device Market

Porter's Five Forces Model

Market Access

Country Healthcare Landscape

Opportunities and Challenges

Appendix

List of Figures

Figure 1: Pharmaceutical Market, Nigeria, Revenue (USD bn), 2010-2017 6

Figure 2: Medical Device Market, Nigeria, Revenue (USD m), 2013-2017 6

Figure 3: Country Profile, Nigeria, 2018 10

Figure 4: Pharmaceutical Market, Nigeria, Revenue (USD bn), 2010-2017 12

Figure 5: Pharmaceutical Market, Nigeria, Revenue forecast (USD bn), 2018-2022 12

Figure 6: Pharmaceutical Exports (USD m), Nigeria, 2010-2017 13

Figure 7: Top Export Partners, Nigeria, 2017 13

Figure 8: Pharmaceutical Imports (USD m), Nigeria, 2010-2017 14

Figure 9: Top Import Partners, Nigeria, 2017 14

Figure 10: Distribution Channels, Nigeria 15

Figure 11: Pharmaceutical Market, Nigeria, Major Players 18

Figure 12: Medical Device Market, Nigeria, Revenue (USD m), 2013-2017 33

Figure 13: Overview of Public Healthcare System, Nigeria, 2018 45

Figure 14: NHIS Programmes, Nigeria, 2018 48

Figure 15: Out-of-Pocket Expenditure (% of total expenditure on health), Nigeria, 2010-2017 49

Figure 16: Change in Price Trend in Healthcare Sector (%), Nigeria, 2010-2017 49

Figure 17: NAFDAC, Organizational Structure, Nigeria, 2018 51

Figure 18: Market Authorization Procedure, Nigeria, 2018 52

Figure 19: New Medical Approval Process, Nigeria, 2018 53

Figure 20: Patent Approval Process, Nigeria, 2018 56

Figure 21: Trademark Approval Process, Nigeria, 2018 57

Figure 22: Clinical Trial Regulation Process, Nigeria, 2018 58

Figure 23: Labelling and Packaging Regulations, Nigeria, 2018 61

Figure 24: Life Expectancy (years), Nigeria, 2010-2017 64

Figure 25: Immunization Rate (%), Nigeria, 2010-2017 64

Figure 26: Major Causes of Mortality, No. of deaths ('000), Nigeria, 2012 65

Figure 27: Major Causes of Male Mortality, No. of deaths ('000), Nigeria, 2016 65

Figure 28: Major Causes of Female Mortality, No. of deaths ('000), Nigeria, 2016 65

Figure 29: Disability-Adjusted Life Years by Major Disease ('000), Nigeria, 2015 65

Figure 30: Health Care Personnel (per 1,000 population), Nigeria, 2009-2011 66

Figure 31: PM2.5 (?g per m3), Nigeria, 2010-2017 67

Figure 32: CO2 Emissions (k tons), Nigeria, 2010-2017 67

Figure 33: Healthcare Expenditure (% of GDP ), Nigeria, 2010-2017 68

Figure 34: Public-Private Share (%), Nigeria, 2010-2017 68

Figure 35: Trade Associations, Nigeria 69

Figure 36: Opportunities and Challenges, Nigeria 71

List of Tables

Table 1: Market Access, Pricing of Medicines, Nigeria, 2018 50

Table 2: Market Access, Summary of registration processes with timelines, Nigeria, 2018 52

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Nigeria, Pharmaceutical Market, Medical Devices, Drivers and Barriers, Major Players, Regulatory landscape, Reimbursement landscape, Porter Five Forces,Opportunities and Challenges

select a license
Single User License
USD 1995 INR 137236
Site License
USD 3990 INR 274472
Corporate User License
USD 5985 INR 411708

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com